Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost, as shown by a large-scale study initiated by UMC Utrecht in collaboration with the Netherlands Cancer Institute, UZ Leuven and Radboudumc.
News | Prostate Cancer
Radiation Boost Lowers Risk of Prostate Cancer Recurrence

January 25, 2021 — An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects ...

Time January 25, 2021
arrow
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.
Feature | Prostate Cancer | By Brian Wodlinger, Ph.D.
Detecting Prostate Cancer With Advanced Micro-ultrasound

Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next ...

Time January 20, 2021
arrow
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH
News | Coronavirus (COVID-19)
Study Shows Sharp Decline in Cancer Screenings During First COVID-19 Surge

January 15, 2021 — In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses ...

Time January 15, 2021
arrow
The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast by Type; PET Product" report has been added to ResearchAndMarkets.com's offering. The prostate cancer nuclear medicine diagnostics market in the US was valued at $194.47M in 2019 and is expected to grow at a CAGR of 10.6% from 2020 to 2027 to reach $431.76M by 2027.
News | Prostate Cancer
US Prostate Cancer Nuclear Medicine Diagnostics Market Outlook

January 13, 2021 — The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast ...

Time January 13, 2021
arrow
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.
News | Prostate Cancer
MRI Frequently Underestimates Tumor Size in Prostate Cancer

January 11, 2021 — A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic ...

Time January 11, 2021
arrow
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
News | Prostate Cancer
Radiation Therapy Has the Greatest Impact on Patient Finances

December 2, 2020 — For men with early-stage prostate cancer, choices about initial treatment carry varying risks of ...

Time December 02, 2020
arrow
 Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that their manufacturing partner Nucleis (Liege, Belgium) has manufactured and shipped their first patient doses of rhPSMA-7.3 (18F), an investigational Prostate-Specific Membrane Antigen (PSMA)-targeted radiohybrid PET imaging agent, currently under evaluation in clinical trials in men with newly diagnosed prostate cancer and suspected prostate cancer recurrence.
News | PET Imaging
Blue Earth Diagnostics Announces First Patient Doses of PET Imaging Agent in Collaboration with Nucleis Radiopharmaceuticals

November 25, 2020 — Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that their ...

Time November 25, 2020
arrow
 MIM Software Inc. announced a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in support of its Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) program.
News | Prostate Cancer
MIM Software Inc. Announces Collaboration with Peter MacCallum Cancer Centre to Improve Patient Management

November 19, 2020 — MIM Software Inc. announced a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in ...

Time November 19, 2020
arrow
During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.
News | Prostate Cancer
Men with Negative Biopsies During Active Surveillance Have Good Outcomes

November 18, 2020 — Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"- ...

Time November 18, 2020
arrow
Penn study supports the use of more testicular shielding for men and children during diagnostics
News | Radiology Imaging
Diagnostic Imaging May Increase Risk of Testicular Cancer

November 16, 2020 — Early and repeated exposures to diagnostic imaging, such as X-rays and computed tomography (CT) ...

Time November 16, 2020
arrow
Minimizing delays to treatment could improve cancer survival rates, say researchers
News | Radiation Oncology
Every Month Delayed in Cancer Treatment Can Raise Risk of Death by Around 10%

November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% higher ...

Time November 10, 2020
arrow
In this retrospective cohort study of men with low-risk prostate cancer followed up for a median of 7.6 years, African American men, compared with non-Hispanic White men, had a statistically significant increased 10-year cumulative incidence of disease progression and definitive treatment, but not metastasis or prostate cancer–specific mortality
News | Prostate Cancer
Active Surveillance Safe for African Americans with Low-risk Prostate Cancer

November 4, 2020 — Previous studies have shown that African American men are 2.4 times as likely to die from prostate ...

Time November 04, 2020
arrow
Metastasis-free survival is a strong surrogate endpoint for overall survival over biochemical failure for men receiving salvage radiotherapy for recurrent prostate cancer
News | Prostate Cancer
MFS Is a Strong Surrogate Endpoint for OS for Men Receiving Salvage RT

November 2, 2020 — An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving salvage ...

Time November 02, 2020
arrow
Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)
News | Ultrasound Imaging
Destroying Cancer Cells with Non-surgical Ultrasound Treatment

November 2, 2020 — Focusing ultrasound energy on a target site in the body to generate heat can burn and destroy the ...

Time November 02, 2020
arrow
Follow up results on first multicenter trial to report outcomes of salvage low dose radiotherapy brachytherapy after external beam radiotherapy for prostate cancer
News | Prostate Cancer
Outcomes of Salvage Low Dose RT Brachytherapy After EBRT for Prostate Cancer

October 30, 2020 — Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) ...

Time October 30, 2020
arrow
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging
Adding Advanced PET Scans to Radiation Treatment Plans for Prostate Cancer Increases Failure-free Survival Rates

October 26, 2020 — Adding the advanced PET radiotracer fluciclovine to conventional imaging to help guide radiation ...

Time October 26, 2020
arrow
A study from Winship Cancer Institute of Emory University (Winship) has the potential to change how patients whose prostate cancer recurs after prostatectomy are treated. The study will be featured in both the plenary session and press program of the American Society for Radiation Oncology (ASTRO) Annual Meeting on Monday, October 26.
News | Prostate Cancer
ASTRO Highlights Winship Study Showing Increased Failure-free Survival in Prostate Cancer

October 24, 2020 — A study from Winship Cancer Institute of Emory University (Winship) has the potential to change how ...

Time October 24, 2020
arrow
The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer
Quantib Receives FDA Clearance for First-to-Market Prostate Solution

October 21, 2020 — Quantib, a market leader in artificial intelligence solutions for radiology, today announced that it ...

Time October 21, 2020
arrow
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence
Ezra Receives FDA Clearance For Prostate Cancer Artificial Intelligence

October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI) ...

Time October 20, 2020
arrow
ASTRO urges radiation oncology benefits management company eviCore to reconsider a move that requires shorter treatment regimens without regard for physician judgement
News | Radiation Oncology
Benefits Manager Policy Disrupts Patient-physician Decision Making for Breast and Prostate Cancer Radiation Treatments

October 2, 2020 — Radiation oncologists expressed serious concerns about a new private insurance coverage policy that ...

Time October 02, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now